CO-DELETION OF 1P/19Q AS PROGNOSTIC AND PREDICTIVE BIOMARKER IN THE LONG-TERM FOLLOW UP OF ANAPLASTIC OLIGODENDROGLIOMA PATIENTS

被引：0
|
作者：
Polivka, J., Jr. [1 ,2 ]
Polivka, J. [3 ,4 ]
Rohan, V. [3 ,4 ]
Repik, T. [3 ,4 ]
Hes, O. [5 ]
Topolcan, O. [6 ]
机构：
[1] Charles Univ Prague, Fac Med Plzen, Dept Histol & Embryol, Prague, Czech Republic
[2] Charles Univ Prague, Fac Med Plzen, Biomed Ctr, Prague, Czech Republic
[3] Charles Univ Prague, Fac Med Plzen, Dept Neurol, Prague, Czech Republic
[4] Fac Hosp Plzen, Plzen, Czech Republic
[5] Charles Univ Prague, Fac Med Plzen, Dept Pathol, Prague, Czech Republic
[6] Fac Hosp Plzen, Cent Imunoanalyt Lab, Plzen, Czech Republic
来源：
ANTICANCER RESEARCH | 2014年 / 34卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
84
引用
收藏
页码：6843 / 6843
页数：1
相关论文
共 50 条
  • [31] CLINICOPATHOLOGIC ASPECT OF 1P/19Q LOSS TO THE INVASIVENESS OR SENSITIVITY OF CHEMORADIOTHERAPY OF THE ANAPLASTIC OLIGODENDROGLIOMA
    Lee, C.
    Kim, M.
    Kang, Y.
    Joo, M.
    Park, S.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1129 - 1129
  • [32] Morphological Diagnosis of Oligodendroglioma in Adult is Highly Predictive of 1p/19q Codeletion
    Alturkustani, Murad
    Zhang, Qi
    Ang, Lee-Cyn
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2020, 79 (06): : 668 - 668
  • [33] Oligodendroglioma Patients with 1p/19q Co-deletion Treated with Early or Delayed Radiation Therapy over the Last Two Decades: A Multi-institutional Report
    Lin, A. J.
    Kane, L.
    Molitoris, J. K.
    Smith, D.
    Badiyan, S. N.
    Wang, T. J. C.
    Kruser, T. J.
    Huang, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E282 - E283
  • [34] IDH-wildtype Glioblastoma with 1p/19q Co-deletion by FISH: An Important Clinical Pitfall
    Umphlett, Melissa
    Rashidipour, Omid
    Vij, Meenakshi
    Hadjipanayis, Constantinos
    Germano, Isabelle
    Houldsworth, Jane
    Crary, John
    Tsankova, Nadeja
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2022, 81 (06): : 458 - 459
  • [35] CHROMOSOME 1P AND 19Q DELETION WITH PREDICTIVE AND PROGNOSTIC VALUE IN LOW-GRADE GLIOMAS
    Pace, A.
    Carapella, C. M.
    Merola, R.
    Sperduti, I.
    Carosi, M. A.
    Fabi, A.
    Mirri, A. M.
    Vidiri, A.
    Cianciulli, A.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1129 - 1129
  • [36] Predicted Frequency of False Positive FISH 1p/19q Co-deletion based on Chromosomal Microarray Analysis
    Ball, Matthew
    Kollmeyer, Thomas
    Praska, Corinne
    McKenna, Michelle
    Giannini, Caterina
    Raghunathan, Aditya
    Jentoft, Mark
    Lachance, Daniel
    Kipp, Benjamin
    Jenkins, Robert
    Ida, Cristiane
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2019, 78 (06): : 525 - 525
  • [37] Absence of IDH Mutation in Oligodendroglial Tumors with 1p/19q Co-deletion: Technical Problem or an Alternate Pathway
    Tanboon, Jantima
    Keser, Hande
    Gultekin, Sakir
    Tihan, Tarik
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2013, 72 (06): : 563 - 564
  • [38] Generation of chromosome 1p/19q co-deletion by CRISPR/Cas9-guided genomic editing
    Li, Chao
    Liu, Zhong
    Zhang, Xiaoxia
    Wang, Huafeng
    Friedman, Gregory K.
    Ding, Qiang
    Zhao, Xinyang
    Li, Hu
    Kim, Kitai
    Yu, Xi
    Nabors, L. Burt
    Han, Xiaosi
    Zhao, Rui
    NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
  • [39] Role of chromosomal 1p/19q co-deletion on the prognosis of oligodendrogliomas: A systematic review and meta-analysis
    Hu, Nan
    Richards, Rachel
    Jensen, Randy
    INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT, 2016, 5 : 58 - 63
  • [40] ANAPLASTIC OLIGODENDROGLIOMA AND OLIGOASTROCYTOMA WITHOUT 1P-19Q CO-DELETION: A MONO-INSTITUTIONAL RETROSPECTIVE STUDY
    Gaviani, P.
    Simonetti, G.
    Innocenti, A.
    Farinotti, M.
    Finocchiaro, G.
    Lamperti, E.
    Botturi, A.
    Pollo, B.
    DiMeco, F.
    Silvani, A.
    NEURO-ONCOLOGY, 2017, 19 : 91 - 91
12345